A Study of JNJ-1761981 in Participants With Solid Tumors

Recruiting

Phase 1

JNJ-1761981A Study of JNJ-1761981 in Participants With Solid Tumors

Sponsor:

Johnson & Johnson Enterprise Innovation Inc.

Code:

NCT07525141

Conditions

Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

JNJ-1761981

Cetrelimab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-04. This information was provided to ClinicalTrials.gov by Johnson & Johnson Enterprise Innovation Inc. on 2026-05-14.